首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
delivery combined with viral hepatitis 相关文献:
Optimized RNA interference therapeutics combined with interleukin-2 mRNA for treating hepatitis B virus infection.
Zai W, Yang M, Jiang K, Guan J, Wang H, Hu K, Huang C, Chen J, Fu W, Zhan C, Yuan Z.
Signal Transduct Target Ther. 2024 Jun 21;9(1):150. doi: 10.1038/s41392-024-01871-8.
PMID:38902241
OSHA Bloodborne Pathogen Standards.
Denault D, Gardner H.
2023 Jul 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
PMID:34033323
Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance.
Meng CY, Sun S, Liang Y, Xu H, Zhang C, Zhang M, Wang FS, Fu YX, Peng H.
Gut. 2023 Aug;72(8):1544-1554. doi: 10.1136/gutjnl-2022-327059. Epub 2022 Oct 31.
PMID:36316098
Lipid nanoparticle-mediated delivery of IL-21-encoding mRNA induces viral clearance in mouse models of hepatitis B virus persistence.
Shen Z, Zhang S, Jiang Q, Liu N, Li F, Gao Z, Pan S, Hao W, Deng Q, Liu J, Zhang J, Xie Y.
J Med Virol. 2023 Sep;95(9):e29062. doi: 10.1002/jmv.29062.
PMID:37665238
Hepatitis C Viral Infection in Children: Updated Review.
El-Guindi MA.
Pediatr Gastroenterol Hepatol Nutr. 2016 Jun;19(2):83-95. doi: 10.5223/pghn.2016.19.2.83. Epub 2016 Jun 28.
PMID:27437184
Hepatocellular carcinoma associated with chronic viral hepatitis. Aetiology, diagnosis and treatment.
Dusheiko GM.
Br Med Bull. 1990 Apr;46(2):492-511. doi: 10.1093/oxfordjournals.bmb.a072412.
PMID:2165844
Recent advances in hepatocellular carcinoma therapy.
Dutta R, Mahato RI.
Pharmacol Ther. 2017 May;173:106-117. doi: 10.1016/j.pharmthera.2017.02.010. Epub 2017 Feb 5.
PMID:28174094
The effect of intrahepatic cholestasis in pregnancy combined with different stages of hepatitis B virus infection on pregnancy outcomes: a retrospective study.
Gao Q, Li X, Wang L, Tan X, Li Z, Xu C.
BMC Pregnancy Childbirth. 2024 Apr 6;24(1):245. doi: 10.1186/s12884-024-06460-9.
PMID:38582906
Therapeutic Application of Nanoparticles in Hepatitis Diseases: A Narrative Review (2011-2021).
Mehrizi TZ, Ardestani MS.
Curr Pharm Biotechnol. 2023;24(5):611-632. doi: 10.2174/1389201023666220727141624.
PMID:35894465
New therapies for chronic hepatitis B.
Bitton Alaluf M, Shlomai A.
Liver Int. 2016 Jun;36(6):775-82. doi: 10.1111/liv.13086. Epub 2016 Mar 14.
PMID:26854115
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3